From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
The value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing
From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
Recent advancements in the field of proteomics have revolutionized the field of multiomics. The SomaScan® Assay from SomaLogic is the only proteomic technology capable of high-plex (measuring over half of the human proteome – 11,000 proteins), high-throughput (rapid processing time and data turnaround), and high sensitivity (measuring both high- and low-abundant proteins) from a single biological sample. Please join us to learn the value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing.
Maik Pietzner, PhD
Berlin Institute of Health at Charité
Universitätsmedizin Berlin, Berlin, Germany
Maik co-leads the group for Computational Medicine at the Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Germany and holds a chair for Health Data Modelling at the Precision Healthcare University Research Institute (PHURI), Queen Mary University of London, UK. He has co-led multiple efforts to associate human genetic variation at scale with intermediate molecular layers, such as proteomics and metabolomics, among various population-based studies that have identified novel pathophysiological pathways and possible treatment targets. His work on protein quantitative trait loci is spearheading the field and he has recently embarked on the integration of electronic health records to systematically augment the space of diagnosis and diseases amendable to in silico prioritisation of novel treatment targets, drug repurposing, or de-risking anchored on rare and common variation in the human genome. His influence on the field is demonstrated by an outstanding track record with publications in Science and the Nature family. Maik obtained his training and PhD in biomathematics at the University of Greifswald graduating with distinction.
From Discovery to Clinical Insights – the power of integrating proteomics and genomics data
A presentation by Maik Pietzner, PhD
More webinars
WebinarLinking the plasma proteome to echocardiographic parameters in patients with chronic heart failure
Recent advancements in proteomic profiling have unlocked new possibilities for understanding the complex mechanisms that drive heart failure. Measuring thousands of proteins simultaneously makes it possible to capture a comprehensive overview of the patient's health state and investigate underlying disease progression at a subclinical level.
WebinarB Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC
In this webinar, Gary Middleton, MD, PhD, and Akshay Patel, PhD, from the University of Birmingham explore the role of the B cell repertoire and autoantibodies in shaping responses to checkpoint blockade immunotherapy in non-small-cell lung cancer (NSCLC). They demonstrate how autoantibody profiling using the i-Ome™ Discovery protein microarray revealed biomarkers predictive of treatment efficacy and immune-related adverse events (irAEs), providing insights into biomarker development and personalized immunotherapy strategies.
WebinarSerum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.